Viewing Study NCT06824103


Ignite Creation Date: 2025-12-24 @ 7:10 PM
Ignite Modification Date: 2026-01-01 @ 11:48 PM
Study NCT ID: NCT06824103
Status: RECRUITING
Last Update Posted: 2025-11-26
First Post: 2025-02-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module